Format

Send to

Choose Destination
Gastrointest Endosc Clin N Am. 2011 Oct;21(4):613-35. doi: 10.1016/j.giec.2011.07.011.

The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world.

Author information

1
Division of Gastroenterology and Hepatology, University of Virginia Health System, Charlottesville, VA 22908, USA. ayw7d@virginia.edu

Abstract

Due to heightened awareness regarding testing for and eradication of infection, the prevalence and incidence of H pylori infection (and by extension the prevalence and incidence of peptic ulcer disease) appear to have declined in recent years. However, antimicrobial resistance is mounting and traditional clarithromycin- or metronidazole-containing triple therapies may no longer be highly effective at eradicating the infection. Combined bismuth- and metronidazole-containing quadruple therapy or sequential 4-drug therapy may be better choices for first-line treatment against this unique pathogen that is ideally suited to survive in the human stomach.

PMID:
21944414
DOI:
10.1016/j.giec.2011.07.011
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center